Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
Benjamin Sinyor, Jocelyn Mineo, Christopher N. Ochner
Journal of Alzheimer s Disease Reports (2020) Vol. 4, Iss. 1, pp. 175-183
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Design, Synthesis, and Pharmacological Evaluation of Embelin–Aryl/alkyl Amine Hybrids as Orally Bioavailable Blood–Brain Barrier Permeable Multitargeted Agents with Therapeutic Potential in Alzheimer’s Disease: Discovery of SB-1448
Vijay K. Nuthakki, Sushil Choudhary, Chilakala Nagarjuna Reddy, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 6, pp. 1193-1219
Closed Access | Times Cited: 12
Sideritis scardica Extracts Demonstrate Neuroprotective Activity against Aβ25–35 Toxicity
Antonis Ververis, Kristia Ioannou, Sotiris Kyriakou, et al.
Plants (2023) Vol. 12, Iss. 8, pp. 1716-1716
Open Access | Times Cited: 12
miRNAs and Alzheimer’s Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population
Virginia Boccardi, Giulia Poli, Roberta Cecchetti, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 634-634
Open Access | Times Cited: 11
Oral Administration of Euonymus alatus Leaf Extract Ameliorates Alzheimer’s Disease Phenotypes in 5xFAD Transgenic Mice
Yoonsu Kim, Minjung Cho, Chan Ho Jang, et al.
Foods (2024) Vol. 13, Iss. 5, pp. 682-682
Open Access | Times Cited: 4
The relationship between gender differences in dietary habits, neuroinflammation, and Alzheimer’s disease
Alison Warren
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Evaluating the antioxidant, anti‐inflammatory, and neuroprotective potential of fruiting body and mycelium extracts from edible yellow morel (Morchella esculenta L. Pers.)
Rida Haider, Luisa Agnello, Shahid Masood Shah, et al.
Journal of Food Science (2025) Vol. 90, Iss. 1
Open Access
Could immunotherapy and regulatory T cells be used therapeutically to slow the progression of Alzheimer’s disease?
Victoria Abbott, Benjamin E. Housden, Annwyne Houldsworth
Brain Communications (2025) Vol. 7, Iss. 2
Open Access
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Wen Xu, Yi Huang, Rongbin Zhou
Cellular and Molecular Immunology (2025)
Open Access
Investigating the therapeutic potential of 1,2,3,4,6 penta-O-galloyl-β-D-glucose in Alzheimer’s disease: a scoping review
Ezaldean A Kahil, Anisha Jackson, Bernadette D’Souza, et al.
Natural Product Research (2025), pp. 1-15
Closed Access
Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease
Beatriz Piniella-Matamoros, Javier Marín‐Prida, Giselle Pentón‐Rol
Journal of Biosciences (2021) Vol. 46, Iss. 2
Closed Access | Times Cited: 26
Menthae Herba Attenuates Neuroinflammation by Regulating CREB/Nrf2/HO-1 Pathway in BV2 Microglial Cells
Yeo Jin Park, Hye Jin Yang, Wei Li, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 649-649
Open Access | Times Cited: 16
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds
Guangcheng Zhong, Xinyue Wang, Jiaqi Li, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 10, pp. 1650-1671
Open Access | Times Cited: 9
Plant-derived extracellular vesicles as potential smart nano drug delivery systems for antioxidant vitamins C and E in Alzheimer's disease
Amina Jiyah, Suleiman Alhaji Muhammad, Abdulwasiu Ibrahim, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105618-105618
Closed Access | Times Cited: 3
Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Philippe Delbreil, Jean‐Michel Rabanel, Xavier Banquy, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114397-114397
Closed Access | Times Cited: 15
Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases
Yu. S. Khotimchenko, Д. Н. Силачев, Vladimir L. Katanaev
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 708-708
Open Access | Times Cited: 14
Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery
Sergey M. Desenko, Nikolay Yu. Gorobets, В. В. Липсон, et al.
The Chemical Record (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 8
The synergistic effect of nanocurcumin and donepezil on Alzheimer's via PI3K/AKT/GSK-3β pathway modulating
Doha M. Beltagy, Nagat F. Nawar, Tarek M. Mohamed, et al.
Prostaglandins & Other Lipid Mediators (2023) Vol. 170, pp. 106791-106791
Closed Access | Times Cited: 8
Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Stefania Merighi, Tino Emanuele Poloni, Anna Terrazzan, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1267-1267
Open Access | Times Cited: 19
Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-κB Pathways in Alzheimer’s Disease: An In Vitro and In Vivo Investigation
Yuanlong Li, Hua Fan, Ming Ni, et al.
Neuroscience (2021) Vol. 484, pp. 140-150
Closed Access | Times Cited: 18
A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?
Jin Jun Luo, William Wallace, John W. Kusiak
Journal of the Neurological Sciences (2022) Vol. 438, pp. 120294-120294
Closed Access | Times Cited: 13
A drug cocktail of rapamycin, acarbose, and phenylbutyrate enhances resilience to features of early-stage Alzheimer’s disease in aging mice
Jackson Wezeman, Martin Darvas, Nadia Postupna, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
The Different Molecular Targets and Its Significant Role in Alzheimer’s Disease: A Review
Chella Perumal Palanisamy, Manimekalai Pichaivel
Asian Journal of Medicine and Biomedicine (2024) Vol. 8, Iss. 1, pp. 111-143
Open Access | Times Cited: 2
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 16
The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis
Urati Anuradha, Anoop Kumar, Rakesh Kumar Singh
Neurological Sciences (2021) Vol. 43, Iss. 1, pp. 285-298
Closed Access | Times Cited: 16
Effects of water‐soluble mangosteen extract on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's disease (WECAN‐AD): A randomized controlled trial
Weerasak Muangpaisan, Puvanant Wiputhanuphongs, Nattapon Jaisupa, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 11

Scroll to top